Routine administrative filing with zero trading signal. No action warranted; monitor upcoming earnings or pipeline catalysts for GSK's next material move.
Price Chart
Executive Summary
GSK filed a Form 6-K disclosing routine dividend reinvestment transactions by three PDMRs (Dr. Hal Barron, James Ford, and Maya Martinez-Davis) in their Executive Supplemental Savings Plan and 401(k) accounts. These are notional, plan-level acquisitions totaling approximately 2,489 ADSs at $49.52 each—entirely mechanical and administrative in nature, with no discretionary insider signal.
Key Facts
- Dr. Hal Barron (Non-Executive Director) acquired 2,279.563 notional ADS at $49.52 via supplemental plan dividend reinvestment.
- James Ford (SVP & Group General Counsel) acquired 53.89 notional ADS at $49.52 via supplemental plan dividend reinvestment.
- Maya Martinez-Davis (President, US) acquired 82.133 notional ADS at $49.52 via supplemental plan dividend reinvestment.
- Dr. Hal Barron also acquired 73 ADS at $49.52 via 401(k) dividend reinvestment.
- All transactions occurred on 2026-08-14 on the NYSE and are plan-driven, not open-market discretionary buys.
Financial Impact
Total notional acquisition ~$123,300 at $49.52/share — immaterial for a $100B+ market cap company.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-007718 |
| Document: 0001654954-26-007718-index-headers.html | 0001654954-26-007718 |
| Document: 0001654954-26-007718-index.html | 0001654954-26-007718 |
| Document: 0001654954-26-007718.txt | 0001654954-26-007718 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access